Pharmacokinetics of methicillin in patients with cystic fibrosis
- PMID: 404369
- DOI: 10.1093/infdis/135.5.828
Pharmacokinetics of methicillin in patients with cystic fibrosis
Abstract
The disposition of methicillin in normal subjects and in subjects with cystic fibrosis (CF) was studied after administration of single intravenous doses of 15 mg/kg. The area under the serum concentration vs. time curve for CF patients was, on the average, only 75% of that found for normal subjects. The low concentrations in serum were caused by more rapid urinary excretion of the antibiotic, with rates of renal clearance averaging 425 ml/min per 1.73 m2 in the patients with CF and 362 ml/min per 1.73 m2 in the normal subjects. No differences were found in volumes of distribution and metabolic clearance rates of methicillin or in rates of creatinine clearance between the two groups of subjects. These data support previous findings with dicloxacillin which show that patients with CF exhibit unusually rapid, active tubular secretion of certain penicillins that may necessitate use of larger doses of these drugs in treatment of infections.
Similar articles
-
Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis.Pediatrics. 1975 Dec;56(6):1038-44. Pediatrics. 1975. PMID: 1196754
-
Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.Pharm World Sci. 1998 Aug;20(4):149-60. doi: 10.1023/a:1008634911114. Pharm World Sci. 1998. PMID: 9762727 Review.
-
Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.Clin Pharmacokinet. 1987 Oct;13(4):228-53. doi: 10.2165/00003088-198713040-00002. Clin Pharmacokinet. 1987. PMID: 3311531 Review.
-
Probenecid pharmacokinetics in cystic fibrosis.Dev Pharmacol Ther. 1991;16(1):7-12. Dev Pharmacol Ther. 1991. PMID: 1879255
-
Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.Clin Pharmacol Ther. 1990 Jan;47(1):73-8. doi: 10.1038/clpt.1990.11. Clin Pharmacol Ther. 1990. PMID: 2295222
Cited by
-
The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.Eur J Clin Pharmacol. 1984;26(2):183-9. doi: 10.1007/BF00630284. Eur J Clin Pharmacol. 1984. PMID: 6723756
-
Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.Clin Rev Allergy. 1991 Spring-Summer;9(1-2):75-86. doi: 10.1007/978-1-4612-0475-6_5. Clin Rev Allergy. 1991. PMID: 1884329 Review. No abstract available.
-
Antimicrobial therapy in neonates, infants and children.Clin Pharmacokinet. 1989;17 Suppl 1:105-15. doi: 10.2165/00003088-198900171-00008. Clin Pharmacokinet. 1989. PMID: 2692934 Review.
-
Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.Antimicrob Agents Chemother. 1984 May;25(5):579-81. doi: 10.1128/AAC.25.5.579. Antimicrob Agents Chemother. 1984. PMID: 6732226 Free PMC article.
-
Pharmacokinetics of drugs in cystic fibrosis.Clin Rev Allergy. 1991 Spring-Summer;9(1-2):169-210. doi: 10.1007/978-1-4612-0475-6_11. Clin Rev Allergy. 1991. PMID: 1884324 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical